RetractedArticleAging2024

APOA5 alleviates reactive oxygen species to promote oxaliplatin resistance in PIK3CA-mutated colorectal cancer.

Yu-Lin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.